Skip to main content
. Author manuscript; available in PMC: 2014 May 23.
Published in final edited form as: J Med Chem. 2013 May 3;56(10):3820–3832. doi: 10.1021/jm400349k

Table 1.

Initial screening data of analogs of lapatinib 1.

graphic file with name nihms-471692-f0007.jpg
Compd GSK Number R1 R2 R3 Tbb EC50 (μM)a,b
2 GW58337A graphic file with name nihms-471692-t0008.jpg Cl H 0.41
3 GW601906A graphic file with name nihms-471692-t0009.jpg Cl F 0.43
4 GW633460A graphic file with name nihms-471692-t0010.jpg Cl F 0.48
5 GW616030X graphic file with name nihms-471692-t0011.jpg Cl F 0.52
6 GW615311X graphic file with name nihms-471692-t0012.jpg Cl F 0.55
7 GW580496A graphic file with name nihms-471692-t0013.jpg Br H 0.56
8 GW576924A graphic file with name nihms-471692-t0014.jpg F F 0.60
9 GW616907X graphic file with name nihms-471692-t0015.jpg Cl F 1.51
1 lapatinib graphic file with name nihms-471692-t0016.jpg Cl F 1.54
melarsoprol49 0.0063
eflornithine50 16.4
pentamidine49 0.0035
SCYX-715851 0.794
a

All EC50 values are ± 7%.

b

Concentration giving 50% inhibition of growth of T brucei brucei Lister 427 cells